Literature DB >> 15165508

Comparison of on-chip and off-chip microfluidic kinase assay formats.

Jude Dunne1, Holly Reardon, Vy Trinh, Ella Li, Javier Farinas.   

Abstract

Kinases represent an important class of targets for pharmaceutical drug development. Microfluidic devices capable of running kinase assays with either an on-chip or an off-chip enzymatic reaction have been developed. For the on-chip assay, reagent addition, mixing, enzymatic reaction, and electrophoretic separation and detection of substrate and product all take place in the channels of the microfluidic chip. For the off-chip assay, the reaction takes place in a microtiter plate, whereas the electrophoretic separation and detection of substrate and product take place in the channels of the chip. To probe differences between the on-chip and off-chip assays, a panel of commercially available kinase inhibitors was assayed at 10 microM against cyclic AMP-dependent protein kinase A, glycogen synthase kinase 3beta, mitogen- and stress-activated protein kinase, and Akt1 using both the off-chip and on-chip assays. Good correlation was observed between inhibition measured by the two methods, with most of the differences in measured inhibition being attributed to compound solubility and enzyme concentration effects. Microfluidic devices represent an attractive platform for kinase assays due to high data quality and the possibility of on-chip assay integration, leading to reagent and labor savings.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15165508     DOI: 10.1089/154065804323056468

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  19 in total

1.  Discovery of Novel Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia.

Authors:  Jing Liu; Chao Yang; Catherine Simpson; Deborah Deryckere; Amy Van Deusen; Michael J Miley; Dmitri Kireev; Jacqueline Norris-Drouin; Susan Sather; Debra Hunter; Victoria K Korboukh; Hari S Patel; William P Janzen; Mischa Machius; Gary L Johnson; H Shelton Earp; Douglas K Graham; Stephen V Frye; Xiaodong Wang
Journal:  ACS Med Chem Lett       Date:  2012-02-09       Impact factor: 4.345

2.  Measuring and interpreting the selectivity of protein kinase inhibitors.

Authors:  Lynette A Smyth; Ian Collins
Journal:  J Chem Biol       Date:  2009-06-06

3.  Microfabricated channel array electrophoresis for characterization and screening of enzymes using RGS-G protein interactions as a model system.

Authors:  Jian Pei; John F Dishinger; David L Roman; Chetwana Rungwanitcha; Richard R Neubig; Robert T Kennedy
Journal:  Anal Chem       Date:  2008-05-09       Impact factor: 6.986

4.  The challenge of selecting protein kinase assays for lead discovery optimization.

Authors:  Haiching Ma; Sean Deacon; Kurumi Horiuchi
Journal:  Expert Opin Drug Discov       Date:  2008-06       Impact factor: 6.098

5.  Digital microfluidic assay for protein detection.

Authors:  Janine Mok; Michael N Mindrinos; Ronald W Davis; Mehdi Javanmard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-21       Impact factor: 11.205

6.  Integrated microfluidic and imaging platform for a kinase activity radioassay to analyze minute patient cancer samples.

Authors:  Cong Fang; Yanju Wang; Nam T Vu; Wei-Yu Lin; Yao-Te Hsieh; Liudmilla Rubbi; Michael E Phelps; Markus Müschen; Yong-Mi Kim; Arion F Chatziioannou; Hsian-Rong Tseng; Thomas G Graeber
Journal:  Cancer Res       Date:  2010-09-13       Impact factor: 12.701

Review 7.  High-content screening in microfluidic devices.

Authors:  Raymond Cheong; Saurabh Paliwal; Andre Levchenko
Journal:  Expert Opin Drug Discov       Date:  2010-08       Impact factor: 6.098

8.  Discovery of Macrocyclic Pyrimidines as MerTK-Specific Inhibitors.

Authors:  Andrew L McIver; Weihe Zhang; Qingyang Liu; Xinpeng Jiang; Michael A Stashko; James Nichols; Michael J Miley; Jacqueline Norris-Drouin; Mischa Machius; Deborah DeRyckere; Edgar Wood; Douglas K Graham; H Shelton Earp; Dmitri Kireev; Stephen V Frye; Xiaodong Wang
Journal:  ChemMedChem       Date:  2017-01-09       Impact factor: 3.466

9.  Discovery of Mer specific tyrosine kinase inhibitors for the treatment and prevention of thrombosis.

Authors:  Weihe Zhang; Andrew L McIver; Michael A Stashko; Deborah DeRyckere; Brian R Branchford; Debra Hunter; Dmitri Kireev; Michael J Miley; Jacqueline Norris-Drouin; Wendy M Stewart; Minjung Lee; Susan Sather; Yingqiu Zhou; Jorge A Di Paola; Mischa Machius; William P Janzen; H Shelton Earp; Douglas K Graham; Stephen V Frye; Xiaodong Wang
Journal:  J Med Chem       Date:  2013-11-20       Impact factor: 7.446

10.  Pseudo-cyclization through intramolecular hydrogen bond enables discovery of pyridine substituted pyrimidines as new Mer kinase inhibitors.

Authors:  Weihe Zhang; Dehui Zhang; Michael A Stashko; Deborah DeRyckere; Debra Hunter; Dmitri Kireev; Michael J Miley; Christopher Cummings; Minjung Lee; Jacqueline Norris-Drouin; Wendy M Stewart; Susan Sather; Yingqiu Zhou; Gregory Kirkpatrick; Mischa Machius; William P Janzen; H Shelton Earp; Douglas K Graham; Stephen V Frye; Xiaodong Wang
Journal:  J Med Chem       Date:  2013-11-20       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.